Atlas Venture Advisors, Inc. - BICYCLE THERAPEUTICS PLC ownership

BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 99 filers reported holding BICYCLE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is 2.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
Atlas Venture Advisors, Inc. ownership history of BICYCLE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2021$12,797,000
+37.0%
307,6960.0%1.52%
+56.2%
Q2 2021$9,342,000
-49.0%
307,696
-49.8%
0.97%
-71.3%
Q1 2021$18,301,000
+66.4%
612,6960.0%3.38%
+37.0%
Q4 2020$10,998,000
-55.8%
612,696
-53.1%
2.47%
-41.1%
Q3 2020$24,898,000
+16.1%
1,306,965
-4.1%
4.19%
-23.5%
Q2 2020$21,449,000
+15.3%
1,362,6960.0%5.47%
-78.3%
Q1 2020$18,601,000
+44.8%
1,362,6960.0%25.18%
+29.7%
Q4 2019$12,850,000
-17.2%
1,362,6960.0%19.41%
+303.1%
Q3 2019$15,521,000
+13.2%
1,362,6960.0%4.82%
-15.1%
Q2 2019$13,709,0001,362,6965.67%
Other shareholders
BICYCLE THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Paradigm Biocapital Advisors LP 3,642,307$73,173,9484.96%
Sio Capital Management, LLC 796,933$16,010,3844.96%
First Light Asset Management, LLC 2,070,853$41,603,4373.95%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 1,281,820$25,751,7643.60%
Deep Track Capital, LP 3,490,506$70,124,2662.71%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,010,976$20,310,5081.10%
HighVista Strategies LLC 92,434$1,856,9990.86%
BRAIDWELL LP 1,289,872$25,913,5280.82%
DAFNA Capital Management LLC 122,200$2,454,9980.76%
Soleus Capital Management, L.P. 391,800$7,871,2620.73%
View complete list of BICYCLE THERAPEUTICS PLC shareholders